Related Experiment Video
Updated: May 21, 2026

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
Effects of beta-blocker use on volume status in hemodialysis patients
Shu-Hong Bi1, Lori Linke, Jimmy Wu
1Division of Nephrology, Peking University Third Hospital, Beijing, PR China. bishh6690@yahoo.com.cn
Background:
Removal and control of excess fluid with dialysis is considered critical for protection against cardiovascular sequelae. Antihypertensive agents including beta-blockers may influence hemodynamics, which may limit fluid removal during hemodialysis (HD).
Methods:
Fifty chronic HD patients underwent bioimpedance measurement before and after a midweek dialysis session. Data on volume status, blood pressure, antihypertensive medications, and bioimpedance were analyzed.
Results:
Patients in the high-volume status group used a significantly higher percentage of beta-blockers than patients in the low-volume status group (54.2 vs. 19.2%, respectively, p = 0.01). Multivariable regression revealed that the use of beta-blockers was independently positively associated with fluid overload (p < 0.05). Intradialytic muscle cramping occurred more often in the beta-blocker group than the control group (44.4 vs. 12.5%, respectively, p = 0.02).
Conclusions:
Our results suggest that the use of beta-blockers was associated with fluid overload in HD patients, and patients being treated with them experienced more intradialytic muscle cramping during dialysis.
Related Concept Videos
Heart Failure Drugs: β-Blockers
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Action of β1 Blockers
Hemodialysis I: Introduction